SCHEMBL5125590

SCHEMBL5125590

N#Cc1ccc(-c2ccc(/C=N/O)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
MMP3 P08254 1/20 0.52
ALDH1A1 P00352 5/20 0.52
KDM4E B2RXH2 2/20 0.52
LMNA P02545 2/20 0.52
GAA P10253 2/20 0.52
HDAC2 Q92769 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.43
RAB9A P51151 1/20 0.42
KIF11 P52732 2/20 0.42
MAPT P10636 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
CA12 O43570 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
CA3 P07451 1/20 0.41
CA6 P23280 1/20 0.41
CA14 Q9ULX7 1/20 0.41
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5125595 1.00 KMT2A (0.53) KMT2AMEN1MMP3ALDH1A1KDM4E
SCHEMBL3821801 0.94 KMT2A (0.58) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL1230125 0.94 KMT2A (0.58) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL2449990 0.94 KMT2A (0.58) KMT2AMEN1ALDH1A1KDM4ELMNA
Hydrochloric Acid SCHEMBL27670220 0.92 KMT2A (0.56) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL5117029 0.83 PTPN5 (0.47)
SCHEMBL5117035 0.83 PTPN5 (0.47)
SCHEMBL29987911 0.80 CYP11B2 (0.45) MMP3HDAC2
SCHEMBL28881566 0.80 CYP11B2 (0.45) MMP3HDAC2
SCHEMBL28881564 0.80 CYP11B2 (0.45) MMP3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414142-B2 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2008-08-19 US disclosed
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators CYP19A1, PGR, GNRHR KMT2A 2335/4885MEN1 776/4885MMP3 3486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.